General Probiotics Inc
St. Paul, MN · Biotech · Private
Probiotic-based therapeutics against SARS-CoV-2 and COVID-19
gprobiotics.com →- Grants
- $2.1M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 2 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: New antibiotic technologies to eliminate Salmonella carriage in poultry | $225,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: New Antimicrobial Technologies to Eliminate Salmonella Carriage in Poultry | $905,622 | |
| Federal grant | Department of Agriculture · Engineered Probiotics To Reduce Clostridia Perfringes And Prevent Necrotic Enteritis In Chicken | $106,500 | |
| Federal grant· 1 of 2 same day | Department of Agriculture · Necrotic Enteritis, In Both Its Clinical And Subclinical Forms, Is A Major Health, Welfare And Performance Disease. Without Technologies To Control Clostridia Perfringens (c. Perf.), The Causal Agent Of The Disease, Producers Are Having A Hard Time To Raise Healthy Birds And Produce Safe Food. The Challenge Is Now Becoming Acute With The Withdrawal Of Antibiotics From Livestock Production.we Propose To Test A New Class Of Safe Live Thaerapeutics That Are Equipped With Antimicrobials That Kill C. | $650,000 | |
| Federal grant· 2 of 2 same day | National Science Foundation · Phase I · SBIR Phase I: Antiviral and Anti-inflammatory Live Biotherapeutics (COVID-19) | $256,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2061 | BIOAXONE BIOSCIENCES, INC. | — | — |
| 2062 | Synthetic Biodesign, LLC | — | — |
| 2063 | Silverpeutics Inc. | — | $12M |
| 2064 | General Probiotics Inc | — | — |
| 2065 | PNEUMOTACTIX, LLC | — | — |
| 2066 | VIRVIO, INC. | — | — |
| 2067 | Bespoke, Inc. | — | $14M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Combinations Of Engineered Antimicrobial Probiotics For Treatment Of Gastrointestinal Tract Pathogensgranted
- Compositions Including Probiotic Bacteria For The Expression And Secretion Of Enterocins To Control Clostridia Perfringens-induced Necrotic Enteritis In Livestock And Related Methodsgranted
- Antimicrobial Recombinant Live Products And Methodsapplication
- Antimicrobial Recombinant Live Products And Methodsapplication
- Compositions Including Probiotic Bacteria For The Expression And Secretion Of Enterocins To Control Clostridia Perfringens-induced Necrotic Enteritis In Livestock And Related Methodsapplication
- Compositions Including Probiotic Bacteria For The Expression And Secretion Of Enterocins To Control Clostridia Perfringens-induced Necrotic Enteritis In Livestock And Related Methodsapplication
- Combinations Of Engineered Antimicrobial Probiotics For Treatment Of Gastrointestinal Tract Pathogensapplication
- Antimicrobial Recombinant Live Products And Methodsapplication
- Combinations Of Engineered Antimicrobial Probiotics For Treatment Of Gastrointestinal Tract Pathogensapplication
- Personalized Bacterial Cancer Vaccinesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.